83 results
-
List item
Herbal medicinal product: Trigonellae foenugraeci semen
Trigonella foenum-graecum L., Fenugreek, F: Assessment finalised, Last updated: 30/08/2022 -
List item
Direct healthcare professional communication (DHPC): Ozempic (semaglutide) solution for injection in pre-filled pen: supply shortage update
Active substance: semaglutide, DHPC type: Medicine shortage, Last updated: 13/03/2023 -
List item
Direct healthcare professional communication (DHPC): INSUMAN RAPID / INSUMAN BASAL / INSUMAN COMB 25 (insulin human): temporary supply shortage
Active substance: insulin human, DHPC type: Medicine shortage, Last updated: 16/01/2023 -
List item
Direct healthcare professional communication (DHPC): Natpar (parathyroid hormone): Discontinuation of manufacturing at the end of 2024 and update on 100mcg shortage
Active substance: parathyroid hormone, DHPC type: Medicine shortage, Last updated: 04/10/2022 -
List item
Direct healthcare professional communication (DHPC): Direct healthcare professional communication (DHPC): NULOJIX (belatacept): Further extension of the temporary restriction in supply up until 3Q 2023
Active substance: belatacept, DHPC type: Medicine shortage, Last updated: 28/09/2022 -
List item
Direct healthcare professional communication (DHPC): Cetrorelix acetate - Cetrotide 0.25 mg Powder and solvent for injection: Temporary Shortage
Active substance: cetrorelix (as acetate), DHPC type: Medicine shortage, Last updated: 09/08/2022 -
List item
Direct healthcare professional communication (DHPC): Visudyne (verteporfin): Information on the continuing supply restriction until end Q1/2022
Active substance: verteporfin, DHPC type: Medicine shortage, Last updated: 05/11/2021 -
List item
Direct healthcare professional communication (DHPC): Visudyne (verteporfin): Information on the continuing supply limitation until end of 2023
Active substance: verteporfin, DHPC type: Medicine shortage, Last updated: 12/08/2022 -
List item
Direct healthcare professional communication (DHPC): Supply Constraint of Sarilumab [Kevzara®]
Active substance: sarilumab, DHPC type: Medicine shortage, Last updated: 09/11/2021 -
List item
Direct healthcare professional communication (DHPC): Metalyse (tenecteplase) 8000 units (40 mg) and 10000 units (50 mg) powder and solvent for solution for injection: temporary supply shortage
Active substance: tenecteplase, DHPC type: Medicine shortage, Last updated: 23/09/2022 -
List item
Direct healthcare professional communication (DHPC): Lymphoseek (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life
Active substance: tilmanocept, DHPC type: Medicine shortage, Last updated: 07/12/2021 -
List item
Direct healthcare professional communication (DHPC): Lymphoseek (tilmanocept) 50 micrograms kit for radiopharmaceutical preparation: temporary extension of shelf life
Active substance: tilmanocept, DHPC type: Medicine shortage, Last updated: 31/01/2023 -
List item
Direct healthcare professional communication (DHPC): Nulojix (belatacept): Further extension of the temporary restriction in supply up until 3Q 2022
Active substance: belatacept, DHPC type: Medicine shortage, Last updated: 17/01/2022 -
List item
Direct healthcare professional communication (DHPC): Pazenir® (paclitaxel formulated as albumin bound nanoparticles) 5 mg/ml powder for dispersion for infusion: temporary supply shortage
Active substance: paclitaxel, DHPC type: Medicine shortage, Last updated: 25/01/2023 -
List item
Direct healthcare professional communication (DHPC): Shortage of Nucala (mepolizumab) Pre-Filled Pen (EU/1/15/1043/003, EU/1/15/1043/004)
Active substance: Mepolizumab, DHPC type: Medicine shortage, Last updated: 27/01/2021 -
List item
Direct healthcare professional communication (DHPC): Supply shortage of Fasturtec (rasburicase) 7.5 mg/5 ml powder and solvent for concentrate for solution for infusion (EU/1/00/170/002)
Active substance: rasburicase, DHPC type: Medicine shortage, Last updated: 17/02/2023 -
List item
Direct healthcare professional communication (DHPC): Natpar (parathyroid hormone) 100 micrograms/dose powder and solvent for solution for injection: expected shortage from June 30th, 2022
Active substance: parathyroid hormone, DHPC type: Medicine shortage, Last updated: 29/04/2022 -
List item
Direct healthcare professional communication (DHPC): Myalepta (metreleptin) 5.8 mg vial: shortage and mitigation plan
Active substance: Metreleptin, DHPC type: Medicine shortage, Last updated: 14/03/2023 -
List item
Direct healthcare professional communication (DHPC): Briviact® (In Italy: Nubriveo®) (brivaracetam 10Mg/ml) Oral solution: Bottles with narrow neck diameter
Active substance: Brivaracetam, DHPC type: Quality defect, Last updated: 20/12/2021 -
List item
Direct healthcare professional communication (DHPC): Menopur (menotropins’ for injection) – quality defect leading to supply shortage
Active substance: menotropin, DHPC type: Medicine shortage, Last updated: 17/04/2023 -
List item
Availability of medicines (updated)
Last updated: 25/05/2023 -
List item
HMA/EMA multi-stakeholder workshop on shortages (updated)
Online, 09:00 - 16:45 Amsterdam time (CET), from 01/03/2023 to 02/03/2023, Last updated: 25/05/2023 -
List item
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party (updated)
Online, 10:00 - 13:00 Amsterdam time (CET), 21/03/2023, Last updated: 04/05/2023 -
List item
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings
Last updated: 24/04/2023 -
List item
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)
Online, 10:00 - 12:00 Amsterdam time (CEST), 19/06/2023, Last updated: 24/04/2023